A carregar...
Intestinal perforation after nivolumab immunotherapy for a malignant melanoma: a case report
BACKGROUND: Nivolumab is a monoclonal antibody against programmed death 1 and has become a standard treatment of advanced melanoma because of its durable response and survival benefits. In this report, we present a case of severe intestinal perforation after nivolumab immunotherapy for malignant mel...
Na minha lista:
| Publicado no: | Surg Case Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572476/ https://ncbi.nlm.nih.gov/pubmed/28842844 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-017-0370-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|